Ibogaine Treatment in South Africa

South Africa is frequently cited as a country where ibogaine treatment is lawful. The scheduling half of that is true. The registration half is not, and the two together decide the answer.

The scheduling

Ibogaine appears in the consolidated schedules under Schedule 6, and the entire entry is one word:

Ibogaine.

It sits alphabetically between hydroxypethidine and isomethadone, among the controlled opioids. It was inserted by government notice in June 2016 and has not been touched since. It appears exactly once in the whole document and in no other schedule.

Schedule 6 is a prescription-control schedule. It is not Schedule 7 or 8, the prohibition schedules, and that difference is real. Ibogaine in South Africa covers the legal position.

The notice that decides it

A month before the scheduling, a separate instrument did the work that actually governs an ibogaine clinic. Government Notice 502 of 4 May 2016 determined that

all preparations which contain ibogaine, either as such or in combination with any other pharmacologically active ingredient(s) shall be subject to registration as medicines falling under Category A

and it applies both to preparations available before the notice and to any that became available afterwards.

No ibogaine product is registered. The regulator’s register of health products holds over twenty-one thousand entries; searching it for ibogaine, iboga or noribogaine returns none. As a control, paracetamol returns hundreds and ketamine returns more than a dozen, so the query works.

Why registrable-but-unregistered is the operative fact

Section 14(1) of the Act provides that, save as provided in that section or in sections 21 and 22A, no person shall sell any medicine subject to registration unless it is registered.

And sell is defined far more broadly than the ordinary word. It includes importing, keeping, possessing for the purposes of sale, supplying, and disposing of to any person, whether for a consideration or otherwise.

A clinic that imports ibogaine, keeps it on the premises and administers it to a patient is selling it in the Act’s sense, three times over.

So the chain is: every ibogaine preparation must be registered, none is, therefore section 14(1) bars its supply except under a case-by-case authorisation.

The route that remains

Section 21 allows the regulator to authorise a named person in writing to sell, during a specified period, to a specified person or institution, a specified quantity of an unregistered medicine.

That is deliberately narrow: per person, per quantity, per period. And the regulator’s own guidance adds a condition that matters here: where a medicine has not been authorised by a recognised foreign regulator, a section 21 application may only be submitted after an application for registration has been made.

No regulator anywhere has approved ibogaine, so that condition applies.

Whether any section 21 authorisation has ever been granted for ibogaine is not publicly documented. The regulator publishes no register of them, so this can be neither confirmed nor refuted from public sources. We say so rather than guessing in either direction.

What the regulator has said

Nothing we could find. A search of the regulator’s own website for ibogaine returns, verbatim, that no posts were found. There is no guidance, no safety statement and no alert discoverable there.

An index of the regulator’s guidelines does list a circular on the scheduling of ibogaine, whose text we could not retrieve. Its existence is worth knowing; its contents are not established.

What not to say about South Africa

Three formulations circulate and all three are wrong.

“Legal for medical use” conflates scheduled with approved. Being in a prescription schedule is not authorisation to sell an unregistered medicine.

“Can be legally prescribed and administered by a registered practitioner” takes the prescription half and drops the registration half. A prescription is necessary and not sufficient.

“Not a scheduled substance in South Africa” is flatly false.

The accurate version is the one this page sets out: prescription-scheduled, registrable, unregistered, and therefore lawfully supplied only under a case-by-case authorisation nobody can show has been granted.

How to evaluate a clinic is what to do with that if a provider there tells you otherwise.